Top Markets
Coin of the day
Boston Scientific Corporation Boston Scientific Corporation

Boston Scientific Corporation

BSX
주식 순위 #210
Boston Scientific Corporation develops, manufactures, and markets medical... Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
주가
$62.83
시가총액
$93.23B
변동 (1일)
-9.17%
변동 (1년)
-31.36%
국가
US
거래 Boston Scientific Corporation (BSX)

카테고리

Boston Scientific Corporation (BSX)의 매출
Dec 2025 기준 매출 TTM: $20.08B
Boston Scientific Corporation의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 $20.08B입니다. 2024년에 회사는 $16.75B의 수익을 올렸으며 이는 2023년의 $14.24B 대비 증가입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
Boston Scientific Corporation의 수익 기록 (2000 ~ 2026)
매년 말 매출
연도 매출 변화
2026 (TTM) $20.08B 0.00%
2025 $20.07B 19.87%
2024 $16.75B 17.61%
2023 $14.24B 12.29%
2022 $12.68B 6.68%
2021 $11.89B 19.92%
2020 $9.91B -7.66%
2019 $10.74B 9.28%
2018 $9.82B 8.57%
2017 $9.05B 7.89%
2016 $8.39B 12.16%
2015 $7.48B 1.31%
2014 $7.38B 3.32%
2013 $7.14B -1.46%
2012 $7.25B -4.89%
2011 $7.62B -2.36%
2010 $7.81B -4.67%
2009 $8.19B 1.71%
2008 $8.05B -3.67%
2007 $8.36B 6.85%
2006 $7.82B 24.48%
2005 $6.28B 11.72%
2004 $5.62B 61.80%
2003 $3.48B 19.08%
2002 $2.92B 9.20%
2001 $2.67B 0.34%
2000 $2.66B 0.00%
유사 기업 또는 경쟁사의 매출
회사 매출 매출 차이 국가
$44.33B 120.81%
US
$25.12B 25.11%
US
$35.49B 76.80%
IE
$35.48B 76.76%
IE
$25.70B 28.01%
DE